A Human Neuronal Cell Model of Endogenous TDP-43 A315T Reveals Altered Protein Dynamics and Disease-Relevant Cellular Dysfunction
Cicardi, M. E.; Antonini, S.; Martorell Serra, I.; Muench, M.; Kinney, N.; Girdhar, A.; Cristofani, R.; Poletti, A.; Sterneckert, J.; Crippa, V.; Bordi, M.; Pasinelli, P.; Guo, L.; Tigano, M.; Trotti, D.
Show abstract
TAR DNA-binding protein 43 (TDP-43) aggregation is the defining pathological hallmark of nearly all cases of amyotrophic lateral sclerosis (ALS), yet physiologically relevant human models that faithfully recapitulate disease-associated TDP-43 proteinopathy and dysfunction remain limited. To cover this gap, we generated a novel human-based model of cortical neurons carrying the endogenous ALS-linked TDP-43 A315T mutation together with an in-frame Dendra2 fluorescent reporter, enabling temporal and spatial monitoring of the protein. Neurons expressing TDP-43 A315T exhibited progressive neurite degeneration, altered neuronal activity, and impaired mitochondrial respiration, recapitulating several ALS-associated phenotypes. Our model also displays autophagy-dependent accumulation of cytoplasmic aggregates of mutant TDP-43 without overt loss of nuclear function, maintaining normal processing of canonical cryptic exon targets. In contrast, experimental induction of TDP-43 nuclear exclusion readily triggered cryptic exon incorporation, demonstrating that the model faithfully reproduces loss-of-function phenotypes under stress conditions. In line with perturbed protein solubility, mutant TDP-43 neurons show increased stress granule (SG) formation at baseline and under oxidative stress condition. Finally, treatment with the RNA chaperone Clip34 significantly reduced TDP-43 aggregation under both basal and oxidative stress conditions as well as its localization to SGs. Taken together, these findings establish a physiologically relevant human model that separates early TDP-43 toxic gain-of-function from basal loss-of-function while providing a robust platform for investigating TDP-43 biology and accelerating therapeutic discovery in ALS.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Divergent and Convergent TMEM106B Pathology in Murine Models of Neurodegeneration and Human Disease 94%
- RBM45 associates with nuclear stress bodies and forms nuclear inclusions during chronic cellular stress and in neurodegenerative diseases 93%
- Blood-spinal cord barrier leakage is independent of motor neuron pathology in ALS 93%
Similar papers in this journal
- Unveiling the crucial neuronal role of the proteasomal ATPase subunit gene PSMC5 in neurodevelopmental proteasomopathies 93%
- α-Synuclein aggregates induce mitochondrial damage and trigger innate immunity to drive neuron-microglia communication 93%
- Expression of ALS-PFN1 impairs vesicular degradation in iPSC-derived microglia 93%
Similar papers in this journal
- ALS mice carrying pathological mutant TDP-43, but not mutant FUS, display axonal transport defects in vivo 96%
- Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia 95%
- Knockout of the LRRK2-counteracting RAB phosphatase PPM1H disrupts axonal autophagy and exacerbates alpha-synuclein aggregation 95%
Similar papers in this journal
- Nuclear depletion of RNA binding protein ELAVL3 (HuC) in sporadic and familial amyotrophic lateral sclerosis 95%
- TMEM106B modifies TDP-43 pathology in human ALS brain and cell-based models of TDP-43 proteinopathy 95%
- Single-cell transcriptomic landscape of the neuroimmune compartment in amyotrophic lateral sclerosis brain and spinal cord 93%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.